Matthew W. Foehr, President and COO at LIGAND PHARMACEUTICALS INC (LGND), sold 22,320 shares at $163.02 ($3.6M) on 2021-11-11, disclosed to the SEC on 2021-11-12.
Open-market sale of $3.6M LGND by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $163.02 | 11,160 | $1.8M | 50.0% |
| 2 | $163.02 | 11,160 | $1.8M | 50.0% |
| Total | $163.02 avg | 22,320 | $3.6M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $35K | — | Filing → |
| VKTX | SELL | 2026-01-05 | $1.1M | — | Filing → |
| OABI | SELL | 2025-12-09 | $27K | — | Filing → |